Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Biotin,Keratin
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved
Sponsor : Dr. Reddy\\\'s Laboratories
Deal Size : Undisclosed
Deal Type : Agreement
Details : Through the agreement, the two companies will establish a joint venture aimed at introducing innovative nutraceutical brands to consumers. The Nestlé Group will license brands like Nature's Bounty (biotin), an approved nutritional supplement for hair, s...
Brand Name : Nature’s Bounty
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 25, 2024
Lead Product(s) : Biotin,Keratin
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved
Sponsor : Dr. Reddy\\\'s Laboratories
Deal Size : Undisclosed
Deal Type : Agreement
MedDay Reports Top-Line Data from Phase III Trial “SPI2”
Details : SPI2 was designed to confirm the results of the first positive Phase III study, MS-SPI, in progressive multiple sclerosis (MS).
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 10, 2020
LOOKING FOR A SUPPLIER?